Precise, consistent dosimetry is crucial for accurate, repeatable research. Here at Xstrahl, we strive to offer researchers all of the tools and support you need to ensure accurate radiation dosage. Learn how we are doing that with our research systems and support team in this new video from our Chief Scientific Officer, Amanda Tulk.
Xstrahl to Highlight Superficial and Orthovoltage Radiotherapy Solutions for Skin Cancer and Selective Benign Conditions at ACRO Summit 2025 in Las Vegas
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Xstrahl 200, a modern orthovoltage radiotherapy solution for treating superficial lesions, skin cancers, and selective benign conditions. Visit Xstrahl at booth 220 at the ACRO Summit 2025 – The Radiation Oncology Summit located at Planet Hollywood, Las Vegas, NV from March 12-15, 2025.
